Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Inductive Bio, a technology company democratizing artificial intelligence (AI) models to transform small molecule drug discovery, announced today that it has raised $25M in Series A financing led by ...

Reveal Technology and Maxar are pleased to announce a partnership to incorporate Maxar's high-resolution satellite imagery and 3D data directly into ...

The objectives of the Phase 1 trial were to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics ... Tonix owns and operates a state-of-the art infectious disease research facility ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

Lantern Pharma Inc. , an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI platform, RADR®, today announced that it has received ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

By Zachary Small and Tim F. Schneider The spring sales of modern and contemporary art often arrive in May with a steady drumroll of paintings whose estimates soar above $50 million — a sign of ...

Explore 400+ artists, new pavilions, and live art experiences at Dubai’s premier art fair World Art Dubai 2025 is now open to the public! Whether you're a serious collector, casual art lover ...

Pharmacokinetics is an area of pharmacology concerned with the time course of absorption, distribution, metabolism and excretion (collectively ADME) of drugs from biological systems in order to ...